Manuscripts

Direct-Acting Antivirals and Risk of Hepatitis C Extrahepatic Manifestations
2025 | JAMA Network | Available online 

Characteristics, Determinants, and Frequency of Persistent Use Among Prescription Opioid Episodes Initiated Postpartum: A population-based cohort study from British Columbia, Canada
2024 | BJOG | Available Online

Association of Hepatitis B Virus Treatment with All-Cause and Liver-Related Mortality Among Individuals with HBV and Cirrhosis: A population-based cohort study                                                                                                  2024 | Lancet | Available Online

Impact of COVID-19 Pandemic on Hepatocellular Carcinoma Surveillance in British Columbia, Canada: An interrupted time series study                                                                                                                                            2024 | JVH | Available Online

Risk of Severe COVID-19-Related Outcomes among Patients with Cirrhosis: A Population-Based Cohort Study in Canada.                                                                                                                                                                    2024 | Viruses | Available Online

Treatment of HCV with Direct-Acting Antivirals on Reducing Mortality Related to Extrahepatic Manifestations: A large population-based study in British Columbia, Canada                                                                                          2024 | Lancet | Available Online

Mortality Rates Among Patients Achieving a Hepatitis C Cure in the Interferon-free Treatment Era: Aata from three population-based cohorts
2023 | BMJ | Available online 

Chronic Hepatitis C Infection is Associated with Higher Incidence of Extrahepatic Cancers in a Canadian Population-based Cohort
2022 | Front. Onc. | Available online 

Association Between Prescription Opioid Therapy for Noncancer Pain and Hepatitis C Virus Seroconversion
2022 | JAMA Network | Available online 

Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study
2022 | Viruses | Available online | Lay Summary

Women in the 2019 Hepatitis C Care Cascade of Care: findings from the British Columbia Hepatitis Testers Cohort Study
2021 | BMC Women's Health | Available online 

Impact of COVID-19 Related Public Health Measures on HCV Testing in British Columbia, Canada: An interrupted time series analysis
2021 | Liver Int | Available online 

The Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs from the Direct-Acting Antiviral (DAA) Era: A population-based study
2021 | Clinical Infectious Diseases | Available online | Lay Summary

Prescription Opioid Treatment for Non-Cancer Pain and Initiation of Injection Drug Use: Large retrospective cohort study
2021 | BMJ | Available online | Lay Summary

Impact of HCV Infection and Ethnicity on Incident Type 2 Diabetes: findings from a large population-based cohort in British Columbia
2021 | BMJ | Available online

Differences in Risk Factors for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection by Ethnicity: A large population-based cohort study in British Columbia, Canada
2021 | Int J Infect Dis. | Available online

The Impact of Direct-Acting Antiviral Therapies for Treatment of HCV on Mortality in a Large Population-Based Cohort Study
2021 | J Hepatol. | Available online

The Impact of Public Coverage of Newer Hepatitis C Medications on Utilization, Adherence, and Costs in British Columbia, Canada
2021 | PLOS One | Available online

Elevated Risk of Colorectal, Liver, and Pancreatic Cancers Among HCV, HBV, and/or HIV (Co)infected Individuals in a Population-Based Cohort in Canada
2021 | Ther Adv Med Oncol. | Available online

Cohort Profile: Development and characteristics of a retrospective cohort of individuals dispensed prescription opioids for non-cancer pain in British Columbia, Canada
2021 | BMJ| Available online

HCV Reinfection Raters After Cure or Spontaneous Clearance Among HIV-Infected and Uninfected Men Who Have Sex with Men
2021 | Liver Int. | Available online

Prenatal Hepatitis C Screening, Diagnoses, and Follow-Up Testing in British Columbia, 2008-2019
2020 | PLOS One | Available Online

HCV Reinfection Rates after Cure or Spontaneous Clearance Among HIV-Infected and Uninfected Men Who Have Sex with Men
2020 | Liver International | In Press | Lay Summary

Drug Related Deaths in a Population-Level Cohort of People Living with and without Hepatitis C Virus in British Columbia, Canada
2020 | International Journal of Drug Policy | In Press

A Computable Phenotype Model for Classification of Men Who Have Sex with Men within a Large Linked Database of Laboratory, Surveillance, and Administrative Healthcare Records
2020 | Frontiers in Digital Health | In Press

Syndemic Profiles of People Living with Hepatitis C Virus Using Population-Level Latent Class Analysis: Informing optimal integration of health services
2020 | International Journal of Infectious Diseases | Available Online

Concurrent Hepatitis C and B Virus and HIV Infections are Associated with Higher Mortality Risk Illustrating the Impact of the Syndemics on Health Outcomes
2020 | Open Forum Infectious Diseases | In Press

Real World Effectiveness of Sofosbuvir/Velpatasvir for the Treatment of Chronic Hepatitis C Infection: A population-based cohort study
2020 | Open Forum Infectious Diseases | Available Online

Comparing Direct Acting Antivirals for Hepatitis C Using Observational Data - why and how?
2020 | Pharamacology Research and Perspectives | In Press

The Impact of SVR from Direct Acting Antiviral and Interferon-Based Treatments for HCV on Hepatocellular Carcinoma Risk
2020 | Journal of Viral Hepatitis | Available Online

Using Population-Level Integrated Health Data to Monitor and Assess Patients’ Progression Across Care and Treatment Continuums
2019 | BC Medical Journal | Available Online

The Population Level Care Cascade for Hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals
2019 | Liver International | Available Online

What is Killing People with Hepatitis C Virus Infection? Analysis of a population-based cohort in Canada
2019 | International Journal of Drug Policy | Available Online

Sustained Virologic Response from Interferon-Based Hepatitis C Treatments Associated with Reduced Extrahepatic Manifestations Risk
2019 | Journal of Hepatology | Available Online

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatatsvir in People who Inject Drugs and/or those in Opioid Agonist Therapy
2018 | Hepatitis Communications | Available Online

Contextualizing Canada's Hepatitis C Virus Epidemic
2018 | Canadian Liver Journal | Available Online

Applying Core Theory and Spatial Analysis to Identify HCV Infection 'Core Areas' in British Columbia, Canada
2018 | Journal of Viral Hepatitis | Available Online

Effect of Opioid Substitution Therapy (OST) and Psychotherapy on HIV Risk Among HCV Infected Individuals
2018 | Clinical Epidemiology | Available Online

Estimating the Impact of Early Hepatitis C Virus Clearance on Hepatocellular Carcinoma Risk
2018 | Journal of Viral Hepatitis | Available Online

Syndemic Characterization of HCV, HBV, and HIV Co-infections in a Large Population-Based Cohort Study
2018 | E Clinical Medicine | Available Online

Real-world Effectiveness of Sofosbuvir-Based Regimens for Hepatitis C Treatment Among People Who Inject Drugs and/or Those in Opioid Substitution Therapy in Canada
2018 | Hepatology Communications | In Press

Hepatitis C virus Reinfection after Successful Treatment with Direct-Acting Antiviral Therapy on a Large Population-Based Cohort
2018 | Journal of Hepatology | Available Online Lay Summary

Differing Profiles of People Diagnosed with Acute and Chronic Hepatitis B Virus Infection in British Columbia, Canada
2018 | World Journal of Gastroenterology | Available OnlineLay Summary

Identifying Injection Drug Use and Estimating Population Size of People who Inject Drugs Using Healthcare Administrative Datasets
2018 | International Journal of Drug Policy | Available Online

Trends in Hepatocellular Carcinoma Incidence and Survival Among People with Hepatitis C: An international comparison
2018 | Journal of Viral Hepatitis | Available Online

The Contribution of Alcohol-Use to Decompensated Cirrhosis Among People with Hepatitis C: An international study
2017 | Journal of Hepatology | Available Online

A Syndemic Approach to Assess the Effect of Substance Use and Social Disparities’ on the Evolution of HIV/HCV Infections in British Columbia 
2017 | PLOS ONE | Available Online | Lay Summary

Hepatitis C Cross-Genotype Immunity and Implications for Vaccine Development
2017 | Scientific Report | Available Online

Late Hepatitis B and C Diagnosis in Relation to Disease Decompensation and Hepatocellular Carcinoma Development
2017 | Journal of Hepatology | Available Online | Lay Summary

Incidence, Risk factors, and Prevention of Hepatitis C Reinfection: A population-based cohort study
2017 | The Lancet Gastroenterology & Hepatology | Available Online

Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and characteristics of linked and unlinked participants
2016 | PLOS ONE | Available Online

Twin Epidemics of New and Prevalent Hepatitis C Infections in Canada: The BC Hepatitis Testers Cohort
2016 | BMC Infectious Diseases | Available Online

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
2016 | Ebiomedicine | Available Online

Long-Term Effect of Sustained Virological Response on Hepatocellular Carcinoma in Patients with Hepatitis C in Canada
2016 | Journal of Hepatology | Available Online

Role of Primary T-cell Immunodeficiency and Hepatitis B Coinfection on Spontaneous Clearance of Hepatitis C: The BC Hepatitis Testers Cohort
2016 | Journal of Viral Hepatology | Available Online

Shift in Disparities in Hepatitis C Treatment form Interferon to DAA: A population-based cohort study.
2016 | Journal of Viral Hepatology | Available Online